Catheters market is expected to grow over the forecast period owing to the increasing prevalence of cardiovascular diseases and growing demand for minimally invasive medical procedures. The other growth drivers of this market are growing incidences of lifestyle induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing population and awareness. These factors are expected to drive the market over the forecast period. For the purpose of conducting therapeutic and diagnostic treatment, flexible and hollow tubes are inserted into the body, which are referred as catheters. As per the recent report published by WHO, by 2030, 25 million people will die due to prevalence of cardiovascular disease. Cardiovascular disease includes hypertensive heart disease, stroke, ischemic heart disease (IHD), aortic aneurysms, cardiomyopathy, rheumatic heart disease (RHD), congenital heart disease, atrial fibrillation, peripheral artery disease (PAD) and endocarditis. Minimally invasive surgeries are now more preferred than normal surgeries, as it has many advantages attached to it, such as shorter duration of stay at hospital, shorter recovery duration, less risk of bleeding and infection, and scars length is short. Quick procedure duration and faster patient recovery time are two important factors towards the rising demand of medical procedures. Over the forecast period, growing demand of minimally invasive procedures in the emerging countries like China and India is expected to fuel the future growth of this market. Over the upcoming forecast period, catheter market is expected to grow at a CAGR of 9.7%. In 2013, the market was valued at $ 24,380.3 million.
Browse
Detail Report with TOC @
Product
Insights
Catheters
market is segmented on the basis of types into urology, cardiovascular,
neurovascular, intravenous and specialty catheters. Among these, cardiovascular
catheters held the largest market share in 2013 due to high incidences of
cardiovascular diseases, increasing patient awareness and availability of high
unmet medical demand in this segment. In 2013, revenue share of this market was
approximately 40.0%. Further, due to adaptation towards minimally invasive
interventional cardiology procedures and introduction of newly developed
product i.e. bio-absorbable stents, has increased demand of these catheters,
and the market is expected to grow nearby to CAGR of 16% over the upcoming five
years. Market penetration rate will significantly elevate, as bio-absorbable
stents are at low re-stenosis rates. Bio-absorbable stents are used for
removing blockage or expand the vessel by inserting a tube or device into the
blood vessel. Advantage of bio-absorbable stents is that it can absorb or
dissolved in the body after sometime of surgery, as compared to traditional
stents. In terms of revenue, catheters are following stents, as it holds 10.0%
market stake due to the increasing demand for angiography catheters. Heart
related disorders such as blood vessel irregularities, congenital heart defects
and atherosclerosis are diagnosed with the help of angiography catheters. A
small incision is made in femoral artery, through which catheter is inserted
and then moved to actual sire.
Regional Insights
Geographically,
the catheters market is studied by segmenting the market into North America,
Europe, Asia Pacific and RoW. North America is dominating the whole market due
to high per capita healthcare expenditure, sophisticated healthcare
infrastructure, rising disposable income, various government or NGO’s
initiatives, and increasing geriatric population. In 2013, North America
generated over 37% of revenue. The growing economies in Asia Pacific such as
India and China region are expected to witness lucrative growth during the
forecast period due to the rising healthcare expenditure, and awareness about
the catheters. Asia Pacific region is expected to grow at a CAGR of 13.5% over
the forecast period.
Request
a Sample copy of This Report @ http://www.hexaresearch.com/sample/31
Competitive
Insights
The
major market players in the Catheters market are Abbott Laboratories, Boston
Scientific Corporation, Arrow International, Coloplast, Medtronic Inc., and
Johnson & Johnson.
Table of
Contents
Chapter 1.
Executive Summary
1.1. Catheters - Industry Summary and
Critical Success Factors (CSFs)
Chapter 2.
Catheters Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Catheters Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Catheters - Company Market Share
Analysis, by Geography, 2013
2.6.1. North America
2.6.2. Europe
2.6.3. Asia Pacific
2.7. Catheters Market PESTEL Analysis, 2012
Browse
Full Report @ http://www.hexaresearch.com/research-report/catheters-industry/
About
Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact
Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - http://www.hexaresearch.com/
